Description

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?

“[LDN] raises hopes of reversing memory loss in old age.”—the Guardian

Over 30,000 copies sold!

Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects.

So why has it languished in relative medical obscurity?

The LDN Book explains:

  • The drug’s origins
  • Its primary mechanism
  • The latest research from practicing physicians and pharmacists

Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices.

The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

The LDN Book: How a Little-Known Generic Drug — Low Dose Naltrexone — Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More

Product form

£20.25

Includes FREE delivery
RRP: £22.50 You save £2.25 (10%)
Usually despatched within 4 days
Paperback / softback by Linda Elsegood

1 in stock

Short Description:

Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory... Read more

    Publisher: Chelsea Green Publishing Co
    Publication Date: 08/03/2016
    ISBN13: 9781603586641, 978-1603586641
    ISBN10: 1603586644

    Number of Pages: 240

    Non Fiction , Health & Wellbeing

    Description

    Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?

    “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian

    Over 30,000 copies sold!

    Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects.

    So why has it languished in relative medical obscurity?

    The LDN Book explains:

    • The drug’s origins
    • Its primary mechanism
    • The latest research from practicing physicians and pharmacists

    Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices.

    The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.

    Recently viewed products

    © 2024 Book Curl,

      • American Express
      • Apple Pay
      • Diners Club
      • Discover
      • Google Pay
      • Maestro
      • Mastercard
      • PayPal
      • Shop Pay
      • Union Pay
      • Visa

      Login

      Forgot your password?

      Don't have an account yet?
      Create account